scispace - formally typeset
Q

Qi-Zhao Zhou

Researcher at Southern Medical University

Publications -  19
Citations -  275

Qi-Zhao Zhou is an academic researcher from Southern Medical University. The author has contributed to research in topics: Secretory protein & Asthenozoospermia. The author has an hindex of 6, co-authored 15 publications receiving 201 citations.

Papers
More filters
Journal ArticleDOI

Comprehensive proteomics analysis of exosomes derived from human seminal plasma

TL;DR: This study provided a more comprehensive description of the seminal exosomes proteome and could also be a resource for further screening of biomarkers and comparative proteomics studies, including those associated with male infertility and prostate cancer.
Journal ArticleDOI

The Expression of Cysteine-Rich Secretory Protein 2 (CRISP2) and Its Specific Regulator miR-27b in the Spermatozoa of Patients with Asthenozoospermia

TL;DR: This study provides the first preliminary insight into the mechanism leading to the reduced CRISP2 expression in asthenozoospermia, offering a potential therapeutic target for treating male infertility or for male contraception.
Journal ArticleDOI

MicroRNA-27a-mediated repression of cysteine-rich secretory protein 2 translation in asthenoteratozoospermic patients.

TL;DR: A novel mechanism responsible for reduced CRISP2 expression in ATZ is demonstrated, which may offer a potential therapeutic target for treating male infertility, or for male contraception.
Journal ArticleDOI

Expressions of miR‐525‐3p and its target gene SEMG1 in the spermatozoa of patients with asthenozoospermia

TL;DR: Previous studies show that the SEMG1 gene is highly expressed in spermatozoa from patients with asthenozoospermia (AZS), however, the underlying molecular mechanisms are not yet clear.
Journal ArticleDOI

AB035. The expression of cysteine-rich secretory protein 2 (CRISP2) and its specific regulator mir-27b in the spermatozoa of patients with asthenozoospermia

TL;DR: This study provides the first preliminary insight into the mechanism leading to the reduced CRISP2 expression in asthenozoospermic patients, offering a potential therapeutic target for treating male infertility or for male contraception.